[
  {
    "ts": null,
    "headline": "Top Analyst Reports for AbbVie, Lockheed Martin & Dell",
    "summary": "Today's Research Daily features new research reports on 12 major stocks, including AbbVie Inc. (ABBV), Lockheed Martin Corporation (LMT) and Dell Technologies Inc. (DELL), as well as a micro-cap stock Hamilton Beach Brands Holding Company (HBB).",
    "url": "https://finnhub.io/api/news?id=5a994b8b2b473c53dcdcf5d2b849bab8ba7032766670133b9b0b73787964499f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741985220,
      "headline": "Top Analyst Reports for AbbVie, Lockheed Martin & Dell",
      "id": 133184480,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Today's Research Daily features new research reports on 12 major stocks, including AbbVie Inc. (ABBV), Lockheed Martin Corporation (LMT) and Dell Technologies Inc. (DELL), as well as a micro-cap stock Hamilton Beach Brands Holding Company (HBB).",
      "url": "https://finnhub.io/api/news?id=5a994b8b2b473c53dcdcf5d2b849bab8ba7032766670133b9b0b73787964499f"
    }
  },
  {
    "ts": null,
    "headline": "Q4 2024 Regenxbio Inc Earnings Call",
    "summary": "Q4 2024 Regenxbio Inc Earnings Call",
    "url": "https://finnhub.io/api/news?id=54a50955bcd029f3120a7b4567f23f92e56771750f221d6c3f335172e3bda14f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741959544,
      "headline": "Q4 2024 Regenxbio Inc Earnings Call",
      "id": 133184481,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Q4 2024 Regenxbio Inc Earnings Call",
      "url": "https://finnhub.io/api/news?id=54a50955bcd029f3120a7b4567f23f92e56771750f221d6c3f335172e3bda14f"
    }
  },
  {
    "ts": null,
    "headline": "3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now",
    "summary": "Many investors view the healthcare sector as a safe haven when the stock market is turbulent.  Here are three no-brainer healthcare stocks to buy with $1,000 right now.  AbbVie's product lineup is led by blockbuster drugs targeting autoimmune diseases, with Rinvoq and Skyrizi delivering especially strong sales growth.",
    "url": "https://finnhub.io/api/news?id=1fcb64ba72c5293d17db314666aaa3d41ddd60f3991245113ebc4f76295dfc8e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741945860,
      "headline": "3 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now",
      "id": 133184482,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Many investors view the healthcare sector as a safe haven when the stock market is turbulent.  Here are three no-brainer healthcare stocks to buy with $1,000 right now.  AbbVie's product lineup is led by blockbuster drugs targeting autoimmune diseases, with Rinvoq and Skyrizi delivering especially strong sales growth.",
      "url": "https://finnhub.io/api/news?id=1fcb64ba72c5293d17db314666aaa3d41ddd60f3991245113ebc4f76295dfc8e"
    }
  },
  {
    "ts": null,
    "headline": "Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.",
    "summary": "Psychiatry was once big business for pharma, with drugs like Prozac making billions. Now a few breakthroughs are reviving interest.",
    "url": "https://finnhub.io/api/news?id=647713b5d7a0f754f1eb422329ff7d6f6b53fbeb68dfd1d173d7250004069c1b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741944600,
      "headline": "Big Pharma Walked Away From Mental Health. Why Some Are Coming Back.",
      "id": 133184431,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Psychiatry was once big business for pharma, with drugs like Prozac making billions. Now a few breakthroughs are reviving interest.",
      "url": "https://finnhub.io/api/news?id=647713b5d7a0f754f1eb422329ff7d6f6b53fbeb68dfd1d173d7250004069c1b"
    }
  }
]